Literature DB >> 2884794

A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells.

K Kasagi, J Konishi, Y Iida, Y Tokuda, K Arai, K Endo, K Torizuka.   

Abstract

A sensitive, precise and practical assay for thyroid stimulating antibodies was developed in which poorly differentiated rat thyroid cells (FRTL-5) were exposed to crude immunoglobulin fractions precipitated from serum with 15% polyethylene glycol under hypotonic conditions. After the incubation at 37 degrees C for 2 h, cAMP released into Hank's medium without NaCl was determined by radioimmunoassay. The removal of NaCl from the isotonic Hank's medium greatly enhanced cAMP production in response to both TSH and thyroid stimulating antibodies. The assay was sensitive enough to elicit an approximately 30-fold increase in cAMP at 10 mU/l bovine TSH. Thyroid stimulating activities measured using FRTL-5 cells significantly correlated with those measured using cultured porcine (r = 0.918, N = 72) or human (r = 0.830, N = 23) thyroid cells. Thyroid stimulating activities were detected in all of the 50 patients with hyperthyroid Graves' disease, the 14 patients with recurrent hyperthyroid Graves' disease, and the 25 patients with ophthalmic Graves' disease. Thyroid stimulating activity was also detected in some patients (9/24, 37.5%) with Hashimoto's thyroiditis whose serum TSH concentrations were higher than 30 mU/l. However, it was completely abolished by pre-treatment of the sera with anti-TSH antibodies. Although thyroid stimulating activities were detected in one of the patients with simple goitre (N = 10) and in one with thyroid cancer (N = 10), none of the patients with silent thyroiditis (N = 7), adenomatous goitre (N = 11), and thyroid adenoma (N = 9) were positive for thyroid stimulating antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884794     DOI: 10.1530/acta.0.1150030

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

1.  Thyroid ultrasonography related to clinical and laboratory findings in patients with silent thyroiditis.

Authors:  M Miyakawa; T Tsushima; N Onoda; M Etoh; O Isozaki; M Arai; K Shizume; H Demura
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.

Authors:  F Akasu; K Takazawa; R Akasu; T Onaya
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

3.  Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.

Authors:  K Kasagi; R Takeuchi; T Misaki; T Kousaka; S Miyamoto; Y Iida; J Konishi
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

4.  Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.

Authors:  K Ikekubo; M Hino; H Ito; T Koh; T Ishihara; H Kurahachi; K Kasagi; A Hidaka; T Mori
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

5.  De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.

Authors:  Cintia E Citterio; Balaji Veluswamy; Sarah J Morgan; Valerie A Galton; J Paul Banga; Stephen Atkins; Yoshiaki Morishita; Susanne Neumann; Rauf Latif; Marvin C Gershengorn; Terry J Smith; Peter Arvan
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

6.  Hyperthyroidism and hypothyroidism in monozygotic twins: detection of stimulating and blocking THS receptor antibodies using the FRTL5-cell line.

Authors:  A Ilicki; C Marcus; F A Karlsson
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 7.  Clinical review: Clinical utility of TSH receptor antibodies.

Authors:  Giuseppe Barbesino; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

8.  Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies.

Authors:  K Kasagi; H Hatabu; S Miyamoto; R Takeuchi; T Misaki; H Sakahara; Y Iida; J Konishi
Journal:  Eur J Nucl Med       Date:  1994-09

9.  Disappearance of thyroid-stimulation blocking antibody by glucocorticoid therapy in a patient with primary myxedema who developed aortitis syndrome during L-thyroxine supplementation.

Authors:  C Shigemasa; T Kouchi; S Taniguchi; Y Mitani; H Mashiba
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

Review 10.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.